These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 33561865)
1. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder. Augier E Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865 [TBL] [Abstract][Full Text] [Related]
2. Potential of GABA Maccioni P; Colombo G CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283 [TBL] [Abstract][Full Text] [Related]
3. Positive allosteric modulators of the GABAB receptor: a new class of ligands with therapeutic potential for alcohol use disorder. Colombo G Alcohol Alcohol; 2024 Mar; 59(3):. PubMed ID: 38566580 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and side effects of baclofen and the novel GABA Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507 [TBL] [Abstract][Full Text] [Related]
5. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators]. Agabio R; Colombo G Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587 [TBL] [Abstract][Full Text] [Related]
6. The GABA Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133 [TBL] [Abstract][Full Text] [Related]
7. GABA Holtyn AF; Weerts EM Curr Top Behav Neurosci; 2022; 52():157-194. PubMed ID: 32808090 [TBL] [Abstract][Full Text] [Related]
9. Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice. Hwa LS; Kalinichev M; Haddouk H; Poli S; Miczek KA Psychopharmacology (Berl); 2014 Jan; 231(2):333-43. PubMed ID: 23975038 [TBL] [Abstract][Full Text] [Related]
10. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators. Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600 [TBL] [Abstract][Full Text] [Related]
11. GABA de Miguel E; Vekovischeva O; Kuokkanen K; Vesajoki M; Paasikoski N; Kaskinoro J; Myllymäki M; Lainiola M; Janhunen SK; Hyytiä P; Linden AM; Korpi ER Addict Biol; 2019 Nov; 24(6):1191-1203. PubMed ID: 30421860 [TBL] [Abstract][Full Text] [Related]
12. The development of medications for alcohol-use disorders targeting the GABAB receptor system. Agabio R; Maccioni P; Carai MA; Gessa GL; Froestl W; Colombo G Recent Pat CNS Drug Discov; 2012 Aug; 7(2):113-28. PubMed ID: 22574677 [TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment. Farokhnia M; Sheskier MB; Lee MR; Le AN; Singley E; Bouhlal S; Ton T; Zhao Z; Leggio L Neuropharmacology; 2018 Jul; 137():230-239. PubMed ID: 29665351 [TBL] [Abstract][Full Text] [Related]
15. Targeting GABAB receptors for anti-abuse drug discovery. Phillips TJ; Reed C Expert Opin Drug Discov; 2014 Nov; 9(11):1307-17. PubMed ID: 25195620 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE). Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice. Li X; Risbrough VB; Cates-Gatto C; Kaczanowska K; Finn MG; Roberts AJ; Markou A Neuropharmacology; 2013 Jul; 70():156-67. PubMed ID: 23376712 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator. Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262 [TBL] [Abstract][Full Text] [Related]